click below
click below
Normal Size Small Size show me how
CS - Y2S1B2
Cardiovascular System
| Disease | Features |
|---|---|
| Death toll of cardiovascular disease | 40% |
| Functional Classification of Heart Disease: Class I | No limitation of physical activity; ordinary physical activity doesn't cause undue fatigue, dyspnea, or anginal pain |
| Functional Classification of Heart Disease: Class II | Slight impairment of physical activity; ordinary physical activity results in symptoms |
| Functional Classification of Heart Disease: Class III | Marked limitation of physical activity; comfortable at rest, but less than ordinary activity causes symptoms |
| Functional Classification of Heart Disease: Class IV | unable to engage in any physical activity without discomfort; symptoms may be present even at rest |
| Most common symptoms of heart disease | dyspnea, chest pain, palpitations, syncope or presyncope, fatigue; none are specific (interpretation depends on entire clinical picture, and diagnostic testing) |
| Signs of heart disease | the inevitable peripheral signs: diaphoresis (sweating), cachectic appearance; cyanosis or pallor; changes in vital signs; diminished peripheral pulses or bruits; exaggerated pulses; jugular venous distention (JVD); elevated central venous pressure (CVP) |
| Dyspnea | difficulty breathing/SOB; when d/t heart disease it's precipitated or exacerbated by exertion; results from elevated left atrial and pulmonary venous pressure or hypoxia |
| Dyspnea: acute onset | or left atrial hypertension may result in pulmonary edema (accumulation of excess fluid in lung tissue); decompensated heart failure |
| Dyspnea: investigation | should be quantified by amount of activity that precipitates it; also common symptom of pulmonary disease (the etiologic distinction may be difficult); SOB may also be found in sedentary or obese individuals, anxiety states, anemia and other illnesses |
| Orthopnea | dyspnea that occurs in recumbancy (when pt lays down); results from inc in CVP; may also be in pulmonary disease or obesity |
| Paroxysmal nocturnal dyspnea (PND) | SOB that occurs abruptly 30min - 2hrs after going to bed and is relieved by sitting or standing up; more specific for cardiac disease but not diagnostic; if pt starts sleeping in a chair he's bad off |
| Chest pain or discomfort commonly result from: | pulmonary disease, pleural disease, musculoskeletal disease, esophageal disorders, cervicothoracic nerve root irritation, anxiety states, cardiovascular disease |
| Myocardial ischemia | poor circulation to myocardium for 5-20min; usu result of coronary artery disease; MOST frequent cause of cardiac pain; often a sensation of discomfort (tight/squeeze/pressure/gas) not pain; leads to potential neglect by pt and misdiagnosis by Dr |
| Explore what chest discomfort means: | jaw pain? arm pain? |
| Angina pectoris: essentials of diagnosis | Precordial chest pain; usu precip by stress or exertion; relieved rapidly by rest or nitrate drugs; electrocardiographic or scintigraphic evidence of ischemia during pain/stress testing; angiogram shows significant obstruction of major coronary arteries |
| Angina pectoris: pathology | usu d/t atherosclerosis; coronary a. spasms at lesion; unusual causes: congenital anomalies, emboli, arteritis or dissection are seen; also occurs w/absence of obstruction w/L ventricular hypertrophy, aortic stenosis, inc metabolic demands |
| Pain of Myocardial Infarction | sudden insufficiency of arterial blood to myocardium d/t occlusion of coronary a.; ischemic symptoms; anxiety/uneasiness; retrosternal/left precordial pain; jaw/shoulder/innner arms/upper abdomen/back; sternal region involved; >20min of pain; senses doom |
| Ischemic pain | often precipitated by exertion, cold temps, stress; usu relieved by rest; not all follow patterns; not related to position or respiration; usu not elicited by chest palpation; in MI, a precipitating factor is usu not present; not MI if reproducible pain |
| Ischemic pain also seen with: | hypertrophy of either ventricle or aortic disease |
| Atypical Chest Pain: not typical for angina pectoris often seen in: | myocarditis, cardiomyopathy, primary pulmonary hypertension, mitral valve prolapse |
| Palpitations | awareness of heartbeat; may be normal; may reflect cardiac output in pts w/o cardiac conditions (exercise, thyrotoxicosis, anemia, anxiety) |
| Palpitations: cardiac abnormalities | produced by inc stroke volume (regurgitant valvular disease, bradycardia); may be d/t cardiac dysrhythmias; |
| Palpitations: ventricular premature beats (PVCs) | may be sensed as extra or "skipped" beats |
| Palpitations: supraventricular/atrial (SVT) or Ventricular tachycardia (VTach or VT) | may be felt as rapid regular or irregular palpitations or "fluttering;" many pts are asymptomatic and feel faint instead; if pts get fixated they become "cardiac cripples" |
| Syncope | loss of consciousness |
| Cardiogenic syncope | most commonly results from sinus node block, atrioventricular (AV) conduction block, or ventricular tachycardia or ventricular fibrillation |
| Neurocardiogenic syncope | vasovagal syncope; inappropriate inc in vagal efferent activity often resulting from precedent inc in sympathetic cardiac stimulation; strain (valsalva) or after getting blood drawn |
| Cardiogenic syncope - continued | few prodromal symptoms; may be occasion for injury; absence of Sx helps distiguish cardiogenic syncope from vasovagal faints, postural hypertension, or seizure; also d/t aortic valve disease and hypertrophic obstructive cardiomyopathy |
| Neurocardiogenic syncope - continued | aka: vasovagal syncope; syncope may follow a brief period of diaphoresis and presyncopal symptoms; may be abrupt in onset, mimicking arrhythmia-induced syncope |
| Signs of heart disese | anxiety, resltessness as with MI; Diaphoresis - suggests hypotension or hyperadrenergic state (precardial tamponade, tachyarrhythmias or MI); cachexia in chronic low output states; cyanosis (central or peripheral) |
| Central cyanosis | due to arterial desaturation; low output states |
| Peripheral cyanosis | reflecting impaired tissue delivery of adequately saturated blood; low output state; polycythemia; peripheral vasoconstriction |
| Vital signs: HR | heart rate (50-90 is normal); High or low may be normal or may reflect noncardiac conditions (anxiety, pain, medication effect, fever, thyroid disease, pulmonary disease, anemia or hypovolemia)...HR inc 10 beats/min for every 1 degree inc in temp |
| Vital signs - if symptoms or clinical suspicion warrents: | order an ECG to diagnose arrhythmia, conduction disturbance, or other abnormality |
| Vital signs: BP | range of normal is wide: even in asymptomatic individuals, systolic below 90 or >140mmHG warrant further evaluation and follow-up; NEVER Dx a cardiac prob w/only one BP reading (it is a beat-beat window)! |
| Vital signs: respirations - Tachypnea | non-specific; respiratory rate >16/min; pulmonary disease and heart failure should be considered |
| arteriosclerotic peripheral vascular disease | most commonly causes diminished peripheral pulses; may be accompanied by bruits |
| Exaggerated pulses may indicate: | aortic regurgitation, coarctation (stricture or narrowing), patent ductus arteriosis, or other conditions that inc stroke volume |
| Carotid pulses | valuable aid to assess left ventricular function |
| Pulses - delayed upstroke | aortic stenosis |
| Pulses - Bisferiens quality | 2 palpable peaks; hypertrophic obstructive cardiomyopathy; mixed aortic regurgitation and stenosis |
| Pulses - pulsus alternans | amplitude of the pulses alternates every other beat during sinus rhythm; occurs when cardiac contractility is very depressed or w/large pericardial effusions |
| Pulses - pulsus paradoxus | decrease in systolic blood pressure during inspiration > the normal 10mmHg; valuable sign of pericardial tamponade, asthma, and COPD |
| Pulses - Jugular Venous Pulsations | provides insight into R atrial pressure; if >3cm above Angle of Louis = inc CVP; if they rise >1cm w/sustained 30sec RUQ pressure (hepatojugular reflex) = inc Central blood volume |
| Pulmonary Examination - Rales "crackles" | heard at lung bases are a sign of Congestive Heart Failure (CHF); may also be caused by localized pulmonary disease |
| Pulmonary Examination - Wheezing and Rhonchi | suggestive of obstructive pulmonary disease but may occur in left heart failure ("cardiac asthma") |
| Pulmonary Examination - Pleural Effusions | with bibasilar percussion dullness and reduced breath sounds; common in CHF |
| Edema | subcutaneous fluid collections appear 1st in lower extremities in ambulatory pts, or in sacral region of bedridden pts; in Heart Disease: edema results from elevated right atrial pressures |
| Heart Sounds: S1 | closing of mitral and tricuspid valves |
| Heart Sounds: S2 | closing of pulmonary and aotic valves; usually split w/2 components (aortic preceding) being separated more during inspiration |
| Heart Sounds: S3 | mid-diastolic sounds; occurs during rapid filling phase of ventricle after closure of aortic and pulmonary valves; may be normal in kids/YAs/pregnancy; Abnormal if ventricle is dysfunctional or mitral/tricuspid regurgitation |
| Heart Sounds: S4 | atrial gallop; triple cadence to heart sounds at rate of 100+ beats; d/t abnormal 3rd or 4th sound in addition to 1st and 2nd; usu indicative of serious disease ("stiff" or "non-compliant" ventricle) |
| Heart Sounds: clicks | high-pitched ejection sounds |
| Heart Sounds: murmurs | valvular disease; pansystolic (holosystolic) when they merge with 1st heart sound and persist thru all of systole |
| Heart Sounds: "ejection" murmurs | when they begin after the 1st heart sound and end before the second sound |
| Heart Sounds: "innocent" murmurs | often vary w/inspiration; diminish in upright position; are most often heard in thin individuals |
| Heart Sounds: "thrills" | palpable vibrations associated with murmurs |
| Unmodifiable risk factors of heart disease | age, male gender, family history of premature heart disease |
| Potentially modifiable risk factors of heart disease | smoking, high BP, blood lipid levels, physical inactivity, diabetes, obesity, psychological conditions, elevated blood homocysteine levels, markers of inflam (CRP), hyperfibrinogenemia, hormone replacement therapy (HRT) |
| Cigarette Smoking Risks: | lung cancer, emphysema, bronchitis; Vascular Disease (coronary, cerebral, peripheral); risk inc w/increasing pack-yrs |
| Effects of Quitting Smoking Cigarettes | inc risk falls rapidly over time; for coronary heart disease, approx 40% of inc risk is removed w/in 5yrs of quitting; it takes several more years of non-smoking to achieve the level associated w/non-smoker |
| High Blood Pressure Risks | cerebrovascular disease and coronary disease; CV morbidity and mortality inc as both systolic/diastolic pressures rise; hypertension is diagnosed on elevated D or S pressures; Objective of management is to achieve normalization of both S and D pressures |
| High Blood Pressure: epidemiology | 50million Americans w/ Systolic >140 or Diastolic >90mmHg; 70% aware of their diagnosis; 50% are receiving treatment; 25% are under control using a threshold of 140/90mmHg |
| High blood pressure: problems | Higher pressure results in higher disease rates; the lower the blood pressure (w/in resonable physiologic limits) the lower the level of risk; several intervention trials have clearly established the value of aggressive Tx of elevated BP |
| Lipid Fractions and Risk of Coronary Heart Disease | in fasting serum, cholesterol is carried on: VLDL, LDL and HCL (the sum = total cholesterol); most labs measure: total chol, total TGs, chol in HDL fraction; |
| Lipid fractions and disease states | some use ratio of total cholesterol:HDL cholesterol as indicator of lipid-related coronary risk; The Lower the ration the Better; this ratio may obscure important information in individual pts; Therefore, evaluate all fractions b/f beginning therapy |
| Ranges of serum lipids | no true "normal;" western pops are 10% higher than Asians; total and LDL chol rise w/age in healthy people; declines seen in acute illness w/exception of TG levels in pancreatitis; Chol levels do not remain constant over time (esp in childhood to adults) |
| Complete lipid profile in pts w/cardiovascular disease | after overnight fasting; Total cholesterol, HDL, TGs, LDL cholesterol |
| Cholesterol screening: | begin at age 20; USP-STF at 35 in M, 45 in W; unless there are other risk factors for coronary heart disease; individuals w/o CAD can be stratified by risk factors (2+ is intermed risk; <2 is low risk) |
| Screening for High Cholesterol | All pts w/CHD or CHD risk equivalents (peripheral artery disease, AAA, symptomatic carotid artery disease; pts w/IDDM); only exception is if lipid lowering in pt is not desirable for other reasons |
| Benefits of Lowering Blood Cholesterol in Men | lowers subsequent coronary heart disease morbidity and mortality and rate of progression of coronary atherosclerosis |
| Benefits of cholesterol lowering in pts w/CHD | reduces cardiovascular events, cardiovascular deaths, all-cause mortality in ment and women w/CAD; aggressive lowering causes regression of plaques in some pts; reduces progression in saphenous vein grafts; can slow/reverse carotid artery atherosclerosis |
| West of Scotland Study and AFCAPS/TexCAPS study | 31% dec in MI in mid-aged men treated w/ Pravastatin (pravachol) compared to placebo; AND, similar results w/Lovastatin (Mevacor); primary prevention studies have found less consistent effect on total mortality |
| Results of reducing cholesterol levels in healthy mid-aged men w/o CHD as primary prevention | reduces risk in proportion to the reductio of LDL cholesterol and the increase of HDL cholesterol; dec rates of MIs, new cases of angina, need for bypass procedures |
| Treatment decisions for Coronary Heart Disease are based on LDL and HDL levels | measurement of total cholesterol is only adequate screening for low-risk individuals; cholesterol >200mg/dL needs fasting LDL and HDL measurement; initial measurement is lease likely to lead to pt misinformation and misclassification |
| Goals for LDL Cholesterol: CHD, PVD or DM | LDL <100 |
| Goals for LDL Cholesterol: Multiple (2+) risk factors | LDL <130 |
| Goals for LDL Cholesterol: 0-1 risk factor | LDL <160 |
| Physical inactivity | association btw less active life and inc risk of coronary heart disease; |
| Exercise | dec likelihood of CHD; favorable effect on HDL w/yrs of exercise; synergistic w/wt loss in lowering LDL/HDL in mod obese men; TGs lowered after single bout of exercise or chronic vigorous exercise |
| Obesity - Framingham Heart Study | weight reduction should lower risk of CHD whether thru lowered BP and/or cholesterol level as a lowered risk factor in itself |
| Diabetes | powerful independent risk factor of CVD; which is a major cause of death in diabetics; aim to normalize glucose levels and monitor other coexistant risk factors |
| Markers of inflammation: another strong risk factor for CAD | CRP (C-reactive ptn) - is the BEST characherized inflam marker; Serum fibrinogen; ESR; Homocysteine |
| High sensitivity CRP | levels >10ug/mL often found in systemic inflam; <1 = low risk for furture CV events; 1-3 = intermediate risk; >3 = high risk for future CV event |
| Coronary Heart Disease | aka: atherosclerotic coronary heart disease; the most common CV disability and death in US; M8x > F, but equal risk after age 70; Peak manifestations: 50-60yo; |
| Risk Factors for CHD | fam hx of onset b/f 50; age; male; blood lipid abnorm; diabetes; insulin resistance/metabolic syndrome; HTN; smoking; elevated homocysteine; CRP; hyperfibrinogenemia; hypoestrogenemia in women |
| CHD: Pathophysiology | abnml lipid metab/excess intake of chol/unsat fats (+ genetics) initiates atherosclerotic proces of fatty streaks (oxid of LDL, macrophage migration, foam cells, smooth muscle migration, fibrous cap, calcification of lesion and narrowing of artery) |
| The Fate of Athrogenic plaques: | remain stable or progress OR rupture/extrusion of lipids/intravascular thrombosis...outcome depends on occlusion or thrombolysis; Tx or spontaneous stabilization; Occlusions result in symptoms of angina or MI |
| Athrogenic Plaque Vulnerability | higher lipid content; higher [macrophage]; very thin fibrous cap; usu in young individuals w/sudden death as the first manifestation of coronary disease |
| Atherosclerosis progression | d/t inflam response in vessel wall; initiated or worsened by infectious agents; high CRP may play role in process (can activate endothelial cell adhesion expression and chomotaxis and inhibits NO synthase to promote lipid deposition/plaque instability) |
| Atherosclerosis; Treatment of lipid abnormalities | delays progression and can produce regression; fewer new lesions develop; endothelial fxn may be restored; coronary event rates are reduced |
| Effects of HMG-CoA reductase inhibitors | "statins" lower LDL cholesterol in clinical trials; prevents death, coronary events and strokes; even in pts who experienced previous coronary events (secondary prevention) |
| Aggressive lipid lowering therapy should be instituted in all pts with: | dyslipidemia and CAD, cerebrovascular or peripheral vascular disease; red of LDL is a primary prevention in pts w/o atherosclerosis (<135mg/dL) |
| Metabolic Syndrome | Insulin resistance and hyperinsulinemia have a role in the pathogenesis of atherosclerosis; inc risk of disease (diabetes is diagnosed if fasting glucose >125) |
| Metabolic Syndrome: Therapeutic Goals | correct hyperglycemia, manage high BP, address dyslipidemias, be cautious of therapies which actually elevate lipids (b-blockers for HTN) or inc insulin resistance w/aggravation of diabetes (niacin) |
| Metabolic Syndrome: features | central obesity, high BP, high TGs low HDL (<40), insulin resistance; LDL should be below 160...100 is best |
| Myocardial oxygen demand | determined by HR, contractility, ventricular wall tension (fxn of ventricular vol and intraventricular pressure); inc in one or more determinants (exercise, stress, adrenergic activity) triggers inc in myocardial O2 demand; ischemia results w/o O2 rise |
| Myocardial Oxygen Supply | governed by coronary blood flow/ability of myocardium to extract O2; heart always takes O2 w/near max efficiency from blood, even under situations of minimal demand so there is little potential for enhanced O2 extraction to counter inc O2 demands |
| Coronary blood flow | can inc several fold in normals d/t vasodilation at arteriolar level; myocardial ischemia results when autoregulatory vasodilation is prevented by stenosis or endothelial dysfxn; coronary blood cannot inc proportional to rising O2 demands |
| Myocardial ischemia | may occur when O2 demands are constant but there is a primary dec in coronary blood flow mediated by: 1. coronary a. spasm, 2. rapid evolution of plaque disruption, 3. intermittent microvascular plugging by platelet aggregates |
| Myocardial ischemia | some episodes are symptomatic causing angina pectoris; others are silent and brought on by emotional/mental stress; |
| Myocardial hibernation and shunting | areas of myocardium that are persistantly underperfused but still viable may develop sustained contractile dysfxn ==> an adaptive response to L ventricular failure; reversible w/coronary revascularization |
| Myocardial hibernation can be identified by: | radionucleotide testing, PET, contrast-enhanced MRI, or its retained response to inotropic stimulation w/dobutamine |
| Myocardial Stunning | occurrence of persistant contractile dysfxn following prolonged or repetitive episodes of myocardial ischemia |
| Acute Coronary Syndromes | ischemic heart dx ranges from angina to actue MI and sudden cardiac death; "Acute Coronary Syndrome" is spontaneous ischemia (unstable angina, non-ST-segment elevation MI and ST-segment elevation MI; single continuum of plaque rupture/thrombus formation |
| Cardiac Diagnostic Testing Modalities | CXR, echocardiogram, electrocardiogram (ECG), transesophageal echocardiography, MRI, Cardiac catheterization and angiography (R and L heart catherization) |
| Other specialized non-invasive cardiac testing procedures | Frequently overused; limited utility for asymptomatic dx; not a substitute for clinical eval; stress testing, ambulatory electrocardiography (Halter monitor), cardiac nuclear medicine tests, cardiac CT |
| Chest x-ray | provides info about normal size of heart, pulmonary circulation, pirmary pulmonary dx and aortic abnormalities; AP, LAT, portable...calcifications in older pts will allow you to visualize aorta more in xrays |
| Electrocardiogram (ECG) | cardiac rhythm, conduction abnormalities, evidence of ventricular hypertrophy/MI/myocardial ischemia; Non-specific ST segment and T wave changes may reflect the above, but are also noted with: E-lyte imbalance/drugs/other conditions |
| Echocardiogram | provides more reliable info about: chamber size, hypertrophy, pericardial effusions, valvular abnormalities, congenital abnormalities; has largely replaced x-ray eval of cardiac dx (non-invasive/widely available/color enhanced) |
| Echocardiography | measure LV size, function, thickness; LV regional wall motion assessed; size of all 4 chambers; morphology of heart valves; allows Dx of: hypertrophic cardiomyopathy, pericardial effusion, mitral valve prolapse, vavlular vegitations, cardiac tumors |
| Doppler Ultrasound | qualitative or quantitative estimation of transvalvular gradients, pulmonary artery pressure, valvular regurgitation, intraventricular shunts |
| Color doppler ultrasound | visually demonstrates patterns and directionality of flow; useful in evaluating congenital heart disease |
| Doppler Echocardiography | ultrasound reflects off RBCs to measure velocity of flow across valves, w/in cardiac chambers, thru great vessels; color flow doppler displays blood velocity in real time superimposd on 2D image; blue toward/red away from transducer; green=turbulance |
| Transesophageal Echocardiography (TEE) | improved quality of echos; info about posterior structures (esp atria, AV valves and prosthetic valves; monitors pts in surgery; sensitive to detecting aortic dissection |
| TEE: detection | severe atherosclerosis of asc. aorta (d/t embolic stroke/CVA/or TIA); detects Latrial thrombi, valvular vegetations, & eccentric mitral regurgitant jets (esp w/prosthetic valves); absense of atrial thrombi identifies pts in atrial fib low risk ebolization |
| Exercise Electrocardiography | aka: stress testing w/bike or treadmill; most useful non-invasive for angina pts; ischemia absent at rest is detected by precipitation chest pain or ST segment depression; combined w/imaging (nuclear/echo/MRI); |
| Bruce protocol for stress testing | increases treadmill speed and elevation every 3 min until limited by symptoms |
| Exercise Elecctrocardiography: Precautions and Risks | one infarction or death/1000 tests; pts who have pain at rest or minimal activity shouldn't be tested; aortic stenosis is contraindicated; stop test when hypotension/ventricular or supraventricular arrhythmias occur >3-4mm ST depression) |
| Exercise Electrocardiography: Indications employed to | confirm Dx of angina; determine severity of limitation of activity d/t angina; assess prognosis in pts w/known coronary disease (incl recovering MIs) by detecting grps at high or low risk; evaluate responses to therapy; screen silent coronary disease |
| Scintigraphic Assessment of Ischemia: Myocardial perfusion scintigraphy | radionucleotide images of blood flow; zone of hypoperfusion (ischemia or scar); if myocardium is viable, defects "fill in" or reverse as blood flow equalizes = reversible ischemia |
| Mycoardial scintigraphy indications | difficult to read rest/exercise ECG (L bundle branch block, baseline ST-T change, low voltage); confirm +exercise ECG in asymptomatic pt; localize ischemia; ischemia vs. infarct; completeness of bypass/angioplasty; prognisis in known coronary disease |
| Cardiolite Scan Result: Normal | <1% risk of cardiac death/MI; Risk factgor modification in addition to current regimen |
| Cardiolite Scan Result: Mildly abnormal | low risk of cardiac death, intermediate risk of MI; aggressive risk factor modification/medical treatment |
| Cardiolite Scan Result: Moderately to severly abnormal | intermediate-to-high risk of BOTH cardiac death and MI; catheterization (possible revascularization)/risk factor modification |
| SPECT (Single photon emission computed tomography) | similar to CT or MRI; visualizes fxnl info about specific organ/system; radioisotope tracer injected, ingested, or inhaled; as isotop decays, gamma rays collected and a CT picture is made |
| Radionucleotide angiography | images L ventricle/measures ejection fraction and wall motion; resting abnormalities in coronary disease = infarction; abnormalities only w/exercise = stress-induced ischemia (may dec fraction..inc in norml pts); less specific older pts w/other heart prob |
| Stress echocardiography | enhances ECGs/alternative to nuc med procedures; echo done during/after exercise; transient depression of segmental wall motion = ischemia; dobutamine (inotropic - contractility) or dipyridamole (persantine) infusion is effective if pt cannot do exercise |
| Cardiac MRI | becoming preferred method of evaluating many cardiac conditions, incl pericardial and congenital abnormalities; used w/gadolinium contrast agents to assess myocardial perfusion and viability |
| Positon emission tomography (PET) | positron agents demonstrate perfusion or metabolism of myocardium; distinguishes "stunned"-transiently dysfxnl myocardium from scar with persistant glycolytic metabolism tracer FDG in regions of dec flow; cyclotrons disturb positron agents |
| Cardiac Catheterization and Angiography | the GOLD STANDARD test for assessment of many hemodynamic and anatomic heart abnormalities; invasive ==> uses intravascular and intracardiac catheters; costly, dangerous, but still necessary |
| Right heart catheterization | convenient to perform bedside/OR/lab; measures R atrial/R ventricular/pulmonary artery/pulmonary capillary wedge pressure, oxygen saturation and cardiac output; provides hemodynamic monitoring for pt |
| Wedge pressure | indicator of left atrial pressure |
| Hemodynamic monitoring | helpful in management/treatment of shock, heart failure, complicated MI, respiratory failure and postoperative hemodynamic instability; |
| Right heart catheterization: Risks | pneumothorax, bleeding, arrhythmias, pulmonary artery rupture, pulmonary emboli, infections |
| Left heart catheterization | via femoral a; evaluates cardiac valves and left ventricular function; mitral stenosis and aortic stenosis quantified by pressure gradients across valves; ejection fraction/regional wall motion; Confirms need for valve surgery/obtain coronary angiograms |
| Cardiac Electrophysiology | electrical impluse starts in SA node (posterior RA), travels across/contracts atria to AV node Bundle of His down R/L bundle branches, depolarizing/contracting ventricles |
| ECG definitions - depolarization | spread of electrical stimulation thru heart |
| ECG definitions - repolarization | return of stimulated heart cells to resting state |
| ECG defined | measure of electrical stimulation of heart; the synchronized pattern of repolarization and depolarization are represented as waves on ECG |
| ECG Complexes - P wave | atrial depolarization; stimulation |
| ECG Complexes - QRS complex | ventricular depolarization; stimulation |
| ECG Complexes - ST segment, T wave, U wave | ventricular repolarization; recovery |
| P wave is at max when: | half the atria depolarizes |
| The electrical charge is 0 when: | all the atria depolarizes |
| The QRS up stroke is when: | half the ventricles depolarize |
| The QRS down stroke is when: | the ventricles are fully depolarized |
| The T-wave is when: | the ventricles are repolarized |
| ECG: PR interval | the time from initial stimulation of atria to initial stimulation of ventricles |
| ECG: ST segment, T wave and U wave (if present) | produced by ventricular repolarization |
| Parts of QRS Complex: first downward deflection | Q wave |
| Parts of QRS Complex: First upward deflection | R wave |
| Parts of QRS Complex: If there is a second upward deflection | R' (R-prime) |
| Parts of QRS Complex: The first downward deflection following an upward deflection | S wave (not a Q wave) |
| Parts of QRS Complex: if there's only one downward deflection | QS wave |
| Electrical, Pressure and Heart Sound Correlation | Peak of P wave begins atrial contraction (1st pressure spike); Peak of QRS begins ventricular contraction (2nd pressure spike); Rise & fall of pressure curve = first and second heart sounds |
| Lead Placements: Chest (6) | The precordial leads define a horizontal or transverse plane and view electrical forces moving anteriorly and posteriorly; R side of sternum, L side of sternum, midclavicular, midaxial, then btw |
| Lead Placements: Limbs (4) | axis measured in 360 degree coronal plane; designated 0 at left; +90 inferiorly; +180 to left; -90 superiorly |
| Lead Placements: Limb lead I | makes L arm positive and R arm negative; angle of orientation is 0 degrees |
| Lead Placements: Limb lead II | makes legs positive and R arm negative; angle of orientation is 60 degrees |
| Lead Placements: Limb lead III | makes legs positive and L arm negative; angle of orientation is 120 degrees |
| Lead Placements: Limb lead AVL | makes L arm positive and other limbs negative; angle of orientation is -30 degrees |
| Lead Placements: Limb lead AVR | makes R arm positive and other limbs negative; angle of orientation is: -150 degrees |
| Lead Placements: Limb lead AVF | makes legs positive and other limbs negative; angle of orientation: +90 degrees |
| Predicting Positive or Negative Deflections: Positive deflection | an atrial or ventricular depolarization that is traveling towards a given lead at less than a 90degree angle |
| Predicting Positive or Negative Deflections: Isoelectric (+ = - deflection) | an atrial or ventricular depolarization that is traveling at a 90degree angle to a give lead |
| Predicting Positive or Negative Deflections: Negative deflection | an atrial or ventricular depolarization that is traveling away from a given lead at an angle greater than 90 degrees |
| Precordial Chest Leads | REMEMBER: the R ventricle lies anteriorly (leads V1 and V2) and medially and L ventrical lies posteriorly and laterally (leads V5 and V6) |
| ECG Leads: V1, V2, V3, V4 | anterior group |
| ECG Leads: I, AVL, V5, V6 | left lateral group |
| ECG Leads: II, III, AVF | Inferior |
| Septal Depolarization | the vector is directed RIGHTWARD and ANTERIORLY; resulting in a positive deflection (R wave) in V1 and a negative deflection (Q wave) in left ventricular epicardial leads (V5) |
| Ventricular Axis: Major activation of L and R ventricles | force is oriented to the Left, inferiorly and posteriorly: In a normal heart: V1 = Negative and V6 = Positive |
| T wave axis: Repolarization | the mean vector is oriented Leftward, inferiorly and anteriorly |
| Cardiac Pacemaker Rate and Rhythm | normally set by SA node in posterior wall of R atrium; if SA node doesn't function properly, there are potential (ectopic) pacemakers in all parts of the heart, including atria, AV node or ventricles |
| Ectopic Atrial Pacemakers | can occur anywhere in heart or atria if SA node is diseased; they are programmed to fire ~75bpm |
| Idionodal rhythms | if atria malfunction, an ectopic AV nodal rhythm is produced ~60bpm |
| Idioventricular rhythms | if atria and AV nodes malfunction, node rhythm is ~40bpm |
| Determining Regular Rhythms | you don't necessarily know that the rhythm is coming from SA node; Estabilishing a regular rhythm allows us to assess accurate rate; Count P waves for each QRS complex and determine that all R wave peaks are equidistant from each other |
| Determining Rate (Quick Method) | count number of large boxes (0.2ms) btw R wave peaks as 300, 150, 100, 75, 60, 50 |
| Rate/Irregular Rhythm | if rhythm is irregular, the quick method of rate determination is not accurate; Use the marks at top of ECG strip; Take the # of R waves in 6 seconds (2 hash marks) and multiply it by 10. |
| R-R intervals are different; No P waves | atrial fibrillation |
| Types of Irregular Rhythms | regular rhythm with extra beat/skips; Regular Irregular Rhythms; Irregularly irregular rhythms; Heart Blocks; Tachycardia (>100bpm) or Bradycardia (<60bpm) |
| Determining Axis | QRS represents depolarization to L ventricle and subsequent contraction; Depolarization occurs from summation of vectors from AV node thru ventricles as "mean QRS vector/axis" |
| Normal QRS Axis | between 0 and +90 degrees |
| Left QRS Axis Deviation | Any axis btw 0 and -90 degrees |
| Right QRS Axis Deviation | Any axis btw +90 and -90 degrees |
| Rapid Determination of Axis: Normal | Leads I and AVF are POSITIVE deflections |
| Rapid Determination of Axis: Right Axis Deviation | If Lead I is DOWN and AVF is UP |
| Rapid Determination of Axis: Left Axis Deviation | If lead I is UP and AVF is DOWN |
| Causes of Right Axis Deviation | large left ventricular infarction; Severe pulmonary hypertension with resultant right ventricular hypertrophy; |
| Causes of Left Axis Deviation | Extreme left ventricular hypertrophy; Extreme obesity (abdominal) pushing up diaphragm; Mild LVH with right ventricular infarct |
| QRS Axis can be determined in AP plane as well: Normal | Lead V2 is directly in front of AV node; If V2 is NEGATIVE, the axis is poterior |
| Atrial and T wave Axis | harbingers of pathology; determine approx axis based on height of positive deflections on 12 lead ECG |
| Block Rhythms: SA blocks | miss a complete cycle d/t lack of impulse from SA node |
| Block Rhythms: AV Node Block (1st Degree) | creates longer delay b/f ventricles are stimulated from P wave; Prolonged PR interval (>0.2s; larger than 5 little boxes) |
| Block Rhythms: AV Node Block (2nd Degree) | occurs when it takes 2 or more atrial impulses to stimulate a QRS; named by the number of blocked P waves; Once the AV node fires, QRS morphology remains normal (indicating the block is in AV node only) |
| Second Degree AV Block: Wenckebach Phenomenon | occurs when PR interval becomes progressively longer until the AV node is not stimulated (no QRS); Mobitz I block; considered a STABLE rhythm, no major concern, but could be a harbinger...1st degree block never drops a beat |
| Second Degree AV Block: Mobitz II | occurs without prolongation of PR interval, but QRS is dropped; an inherently UNSTABLE rhythm |
| Third Degree Hear Block: Complete Heart Block | no atrial stimulation of AV node (no association btw atria and ventricles); Ventricles must be paced independently; COMPLETELY UNSTABLE; P wave is buried in QRS - they have no correlation; dissociation; ventricular escape; Pt needs a pace maker!!! |
| Complete Heart Block | the pacemaker must be the AV node or the ventricles; location is distinguished by ventricular rate and QRS morphology |
| Bundle Branch Block | occurs in either Right or Left side; a delay in conduction creates delay in ventricular firing; REMEMBER: both ventricles fire simultaneously normally |
| Bundle Branch Block: split ventricular firing | results in an R and R' wave; QRS interval is >0.12sec or 3 small boxes |
| Right Bundle Branch Block | anterior chest leads look at R ventricle (V1 and V2); the Left ventricle fires first |
| Left Bundle Branch Block | the R-S-R' is evident in lateral chest leads on left ventrical (V5 and V6); Right ventricle fires first |
| General Principles of Bundle Branch Blocks: Rate dependent | BBB only manifests on ECG over a certain rate |
| General Principles of Bundle Branch Blocks: Incomplete BBB | R-S-R' exists with a normal QRS interval |
| General Principles of Bundle Branch Blocks: Myocardial Infarction | may not be diagnosed w/ coexisting LBBB |
| General Principles of All Blocks: STABLE Rhythms | First and Second Degree AV Blocks (variable rate and Wenckebach) and Chronic BBB |
| General Principles of All Blocks: UNSTABLE Rhythms | Mobitz II second degree AV block, Newly-formed BBB, and Third Degree AV blocks |
| Step by Step Approach to ECG Reading | 1. Quickly assess normal rhythm; 2. Determine Rate; 3. Determine Axis; 4. Measure PR-interval; 5. Measure QRS-interval; 6. Evaluate for Blocks; 7. Assess for Pathology |
| Atrial Abnormality and Hypertrophy: Lead II | evaluates atria as the most positive vector of depolarization |
| Atrial Abnormality and Hypertrophy: Lead V1 | evaluates atria d/t its position on the chest |
| Atrial Abnormality: Left Atrium | Broad, humped P waves in lead II; Biphasic, widened P wave in V2 w/significant negative deflection |
| Atrial Abnormality: Right Atrium/Pulmonale | Peaked P wave in Leads II and V1 |
| Left Ventricular Hypertrophy | deepens the S wave in V1 and heightens the R wave in V6 |
| Right Ventricular Hypertrophy | causes RAD with tall R wave in V1 and Biphasic complex in V6 |
| Left Ventricular Hypertrophy | sum of S wave in V1 and R wave in V5 or V6 >35mm; R wave >11mm in lead aVL; Associated with "strain pattern" repolarization abnormality; Horizontal (0) axis and widened QRS or frank BBB; Secondary LAE |
| Fascicular Blocks (hemiblocks) | while the RBB is one wire, the Left divides into anterior and posterior fascicles; Either of these fascicles may be blocked, but do not widen QRS, only change the axis |
| Left Anterior Fascicular Block (LAFB) | left axis deviation w/o widened QRS, hypertrophy, or strain pattern; a fairly common block |
| Left Posterior Fascicular Block (LPFB) | difficult Dx to make, as other causes of RAD occur w/o concommitant abnormalities; RAD w/o QRS widening of LVH; Isolated case is rare; can also have bifascicular and trifascicular blocks |
| Ischemia | lack of blood supply to muscle; Represented by: symmetrically inverted T waves and ST segment depression w/normal a T wave |
| Injury | ongoing (acute) injury resulting in prolonged ischemia; ST elevation may be 1mm or more; T waves may be normal, inverted, or hyperacute (peaked) |
| Infarction | irreversible injury resulting from prolonged injury; myocardial cell death may be subendocardial or transmural; localized by the leads that they are seen in |
| Transmural Infarction | full thickness myocardial injury; production of significant Q waves signify a completed infarction (insignificant Q waves occur normally) |
| Evolving Infarction | ST elevation and peaked T waves...24hrs later: ST elevation with Q waves and loss of R waves |
| Reversible Ischemia | ST depression signifying ischemia of subendocardial injury REVERSED following nitroglycerin administration |
| Miscellaneous ECG Effects: Moderate Hyper K+ | Wide, flat P wave; Wide QRS; Peaked T wave |
| Miscellaneous ECG Effects: Extreme Hyper K+ | No P wave; Wide QRS |
| Miscellaneous ECG Effects: Moderate Hypo K+ | Flat T wave; U wave |
| Miscellaneous ECG Effects: Extreme Hypo K+ | Prominent U wave |
| Miscellaneous ECG Effects: Hypercalcemia | shortens repolarization; short Q-T interval |
| Miscellaneous ECG Effects: Hypocalcemia | prolongs repolarization; prolonged Q-T interval |
| Pericarditis | diffuse flate ST elevations across precordium w/reciprocal ST depression in aVR; Low amplitude R waves w/all leads affected |
| Sinus Arrhythmia | may be normal if regularly irregular and corresponds to breathing; IF irregular, irregular it is due to sick sinus rhythm secondary to CAD (varying rhythm w/ identical P waves) |
| Multifocal Atrial Rhythms | characterized by changing P wave morphology, indicating multiple atrial ectopic foci; If P wave is negative atrial pacemaker is in Left atrium; QRS conducts normally, although irregular, irregular rhythm |
| Atrial Fibrillation | atrial "bag of worms" w/multiple atrial foci creating artificial baseline w/o P waves; Rhythm is always irregular since only random impulses reach the AV node; Rhythm may be tachycardic or bradycardic |
| Premature Rhythms | premature atrial contractions, premature AV nodal contractions, Premature Ventricular contractions |
| Atrial Premature Beats (PACs) | premature ectopic atrial focus that produces different morphology P wave that originates early; AV node picks up and transmits impulse normally |
| AV Nodal Premature Beats | Premature ectopic foci originates from AV node; Complex will have no P wave, but the QRS will be conducted thru the normal bundle branch system |
| Premature Ventricular Contraction (PVCs) | ectopic focus originates from ventricle (thus, no P wave); generally a wide complex d/t myocardial conduction instead of BB conduction; there is a compensatory pause afterwards |
| PVC Properties | may be multifocal or unifocal; they may be coupled w/normal beats; if RIR - may name based on occurrence; may be isolated or occur in runs (mulit/unifocal) |
| A PVC Run of 4 or more: | Ventricular Tachycardia (v-tach) |
| When do we worry about PVCs? | when there's more than 6/min; Multifocal PVCs; long runs of PVCs (esp if they don't perfuse); PVCs that fall on T waves |
| Escape Beats | Atrial Escape Beats, AV Nodal Escape Beats, Ventricular Escape Beats, Sinus Arrest |
| Atrial Escape Beats | occur after a pause; P wave morphology is different d/t ectopic foci; Atria become "impatient" with lack of sinus beat |
| AV Nodal Escape Beats | after pause, NO atrial ectopic focus fires, so AV fires; QRS appears normal d/t normal AV node - bundle branch conduction |
| Ventricular Escape Beats | ventricles fire if atria or AV node do not fire after sinus pause; essentially identical to PVCs (only w/o being premature) |
| Sinus Arrest | during sinus pause, no new ectopic pacemaker fires; the sinus node may send out an escape beat after 2 cycles have been missed |
| Tachyarrhythmias | supraventricular tachycardia, ventricular tachycardia, atrial flutter, ventricular flutter, ventricular fibrillation |
| Supraventricular Tachycardia | may originate in AV node or atria; Generally RIR; rate usu >150; |
| Supraventricular Tachycardia: Paroxysmal Atrial Tachycardia (PAT) | if P waves are discernable |
| Supraventricular Tachycardia: Paroxysmal Nodal Tachycardia (PNT) | if no P waves are discernable |
| Atrial Flutter | atrial ectopic pacemaker is firing at 250-350bpm! P waves identical to unifocal atrial pacemaker; Only occasional atrial stimuli will fire the ventricle; Named for the block (2:1, 3:1, etc) |
| Ventricular Tachycardia | ventricular ectopic pacemaker; rate >150; run of 4+ PVCs; highly UNSTABLE rhythm |
| Ventricular Flutter | produced by single ectopic ventricular focus; rate bts 200-300bpm; highly UNSTABLE rhythm |
| Ventricular Fibrillation | multiple ventricular foci causing chaotic twitching of ventricles; ventricular "bag of worms;" there is no effective pumping or cardiac output! |
| Asystole | complete lack of electrical activity and pumping of heart; along w/V-fib it is considered Cardiac Arrest; not always a perfectly flat line |
| 4 Major Behavioral Risks that can be modified | Smoking (cigar, cigarette, marijuana, pipe, etc); Diet (trans-fat consumption, inc produce, low CHO/switch to whole grains); Exercise (CV fitness); Weight control (BMI <30, ideally <25) |
| Tobacco dependence | a chronic disease that deserves treatment for users willing to quit, unwilling to quit and former users; the most effective intervention tool to reduce illness, prevent death, and increase quality of life |
| Patients willing to quit using tobacco: treat with the "5 As" | Ask, advise, assess, assist, arrange |
| Patients unwilling to quit tobacco at this time should be treated with the "5 Rs" motivational intervention | relevance, risks, rewards, roadblocks, repetition |
| Patients who recently quit tobacco should be provided with | relapse prevention treatment |
| Counseling/behavioral therapies found effective for tobacco cessation | practical counseling (problemsolving/skills training); social support (intra-treatment); secure social support outside treatment (extra-Tx social support) |
| Smoking | the single most damaging acquired behavior, 75% of alll lung cancers can be prevented |
| Surgeon General Report on Diseases Associated with Smoking | SOB, exacerbationo of asthma, harm to pregnancy, impotence, infertility, inc serum CO; MI, stroke, cancers (lung, oral, larynx, pharynx, esophagus, pancreas, bladder, cervix); COPD; lung cancer/heart disease in family (low birth weight, SIDS, OM, URI/LRI) |
| Why is smoking a difficult habit to break? | psychological, chemical, social dependence |
| Prevention/Cessation Strategies | counseling, nicotine replacement therapy (NRT), *Combo of both is BEST;* 80% will need to "quit" more than once |
| Counseling: Prevention | usu targeted at schools (peers, advertising); more of a public health issue w/questionable success rate |
| Counseling: Cessation | assessment with 5As and 5Rs |
| 5As: Ask | identify and document tobacco use status for every pt at every visit |
| 5As: Advise | in a clear, strong, personalized manner, urge every tobacco user to quit |
| 5As: Assess | is the tobacco user willing to make the quit attempt at this time? |
| 5As: Assisst | for the pt willing to make a quit attempt, use counseling and pharmacotherapy to help him/her quit |
| 5As: Arrange | schedule follow-up contact, in person or by telephone, preferably w/in the first week after the quit date |
| Smoking Cessation Counseling | ID the problem (how many cigarettes are too many? 1); Compute pack years (2packs/day for 10yrs = 20pack years...document) |
| Smoking Cessation Counseling: Cold turkey | is pt really capable? this is the toughest way; if it fails they will lose their will power; try to convince them not to do it cold turkey |
| Smoking Cessation Counseling: Establis | a gradual decrease in consumption followed by an exact quit date; make a contract; be prepared to repeat |
| Smoking Cessation Plan | remove all cigs from house and ration them out per day; tell people you are quiting for moral support; replace oral stimulation w/sugarless gum; find a support person/group; call Dr if you break contract (usu 4 wks, w/ a decrease in consumption each week) |
| Nicotine Replacement Therapy | done w/patches, inhaler, nasal spray or gum with stages of nicotine concentration (21mg, 14mg, 7mg); Begin replacement after quit date to avoid incorrect usage |
| Other Smoking Cessation Pharmacotherapy | First-line Bupropion (wellbutrin); 2nd line - Clonidine, Nortriptyline; these are categorized as anti-depressants that have been shown to decrease cravings/desires |
| Dieting | think of diets as either losing weight or maintaining neutral wieght; exercise is not a substitute for dieting |
| Body Mass Index | current standard for determining obesity; weight in kg/height in meters^2 |
| Weight loss plans | you can lose weight w/o exercise, but it helps on many levels |
| Low fat diet: | label reading and difficult eating regimen |
| Low CHO diet: | label reading, some degree of regimented eating |
| Low caloric intake diet: | simple plans, easy to follow, but poorly sustainable |
| Approach to weight loss | same as w/smoking cessation; ID eating habits (actual food consumed); discuss options w/pt (rapid loss, gradual, strict regimen, less intense, etc); establish a plan with a contract |
| Role of insulin | most powerful stimulator of CHO metab/fat storage default; most powerful antagonist of catabolic processes (glycolysis, gluconeogenesis); you cannot lose weight when insulin is ciruculating in blood stream (tough for diabetics/cortisol pts) |
| Low fat diet | eliminate as many fats as possible (esp trans and saturated); ZONE and South Beach programs; distractors: it's very hard to find food w/o fats (must prepare at home); poor efficacy, slow; intense label reading |
| Low caloric intake | starvation concept; <2000cal/day usu achieves wt loss (1250cal/day = 1kg dec in 2wks); Slim Fast, Optifast, Weight Watchers; Benefits - quick wt loss, support grps; Distractors: had to maintain; Weight Watchers provides very gradual results |
| Low Carbohydrate | Atkins or Atkins-like; does not raise cholesterol levels; Benefits - produces moderate rate of wt loss; large variety of flavorful foods (best for diabetics dt minimal effect on insulin); Distractors - requires complex learning curve/label; not vegetarian |
| Pharmacotherapy for Weight Loss: Phenteramine | metabolic stimulant; can use up to 60 days |
| Pharmacotherapy for Weight Loss: Sibutramine | anti-depressant; reuptake inhibitor of seratonin and NE; found to have independent wt loss properties |
| Pharmacotherapy for Weight Loss: Orlistat | inhibits lipase in intestine (sits in intestines to force fats thru GI; Diarrhea side effect cause many pts to quit |
| Guidelines for Activity Prescription | meet safety, effectiveness, education/motivation criteria; appropriat warm-ups and cool-downs should be emphasized; appropriate "prescriptions" should pay attention to conditions that may worsen during certain activities |
| FITT Principle: Frequency | 3-5 days/wk; be careful to establish a regular habit before recommending levels that may not be sustainable in long term |
| FITT Principle: Intensity | to avoid musculoskeletal injury and promote compliance; start low-moderate intensity and gradually progress over wks/months to more vigorous efforts; increase duration rather than intensity to optimize caloric expenditure |
| FITT Principle: Time | 30-60min using gradual progression (ex: multiple short bursts are as good as single long bout) |
| FITT Principle: Type | low-impact activites that are convenient, accessible, and perceived as enjoyable by the participant (walking, cycling, aerobics, water exercise) |
| FITT: improve cardiorespiratory fitness in healthy, overweight, or obese adults - moderate intensity | estimated using 55-70% of age-predicted maximal heart rate |
| Strength/Resistance Training | recommended as adjunct to aerobic conditioning bc is assists in maintaining BMR and imp strength and performance of activities of daily living; 3-5x/wk with 1 set of 8-15 repetitions with 8-10 different exercises for all major muscle groups |
| Daily Lifestyle Activities | should be emphasized to inc overall physical activity levels and energy expenditure (climbing stairs, walking greater distances, gardening, house cleaning) |
| The most common cyanotic heart disease occurs from a single event | Tetralogy of Fallot; dt undivided chambers/outlet from bulbus cordis (normally v-septum is composed of 2 segments from top and bottom/fusion in middle; failure of outlet septum causes VSD, pulmonary stenosis, overriding aorta, R ventricular hypertrophy) |
| Angiogram of Tetralogy of Fallot | right cath; R --> L shunt thru VSD; pulmonary stenosis visualized; deox blood passes into aorta (the problem is that too much deox blood is being circulated to body and not to lungs) |
| Most common cyanotic newborn disease | Transposition of the Great Arteries; aorta from R ventricle, pulmonary artery from L ventricle; sets up 2 completely independent circuits and baby's O2 saturation is practically 0 (exception: patent foramen ovale); |
| Transposition repair | aorta and pulmonary aa are switched; opening in atrial septum is closed; patent ductus arteriosus is divided and closed off; coronary arteries are re-implanted |
| Truncus arteriosus | pulmonary aa arise from aorta; truncal valve (occasionally quadracuspid, stenotic or insufficient) overrides the VSD; VSD is extremely large and lungs get flooded w/blood |
| Tricuspid Atresia | cyanotic; atretic (missing) tricuspid valve; hypoplastic R ventricle; atrial septal defect; pulmonary stenosis; *there is only one pumping chamber; surgery bypasses R ventricle and vena cava is connected to R pulmonary artery; L ventricle dilates |
| Total anomalous pulmonary venous return | pulmonary veins drain below the diaphragm and are obstructed; atrial septal defect |
| Acute Rheumatic Fever | systemic (heart/joints/skin/CNS/SQ tissues) infam dx; delayed/dt pharyngeal GAS infxn; its greatest significance relates to the heart (acute and chronically) |
| Worldwide impact of ARF | declining in developed world except in lower socioeconomic groups and developing nations |
| How is diagosis of ARF established?? | Jones Criteria; 2 major or 1 major + 2 minor; mimetic flares |
| Major Jones Criteria Manifestations | carditis, polyarthritis, chorea, E. marginatum, SQ nodules |
| Supporting evidence of antecedent GAS infection | + throat culture or rapid strep antigen test; elevated or **rising antibody titer** |
| Minor Jones Criteria Manifestations | Clinical findings (arthralgia, fever); Lab findings (inc ARP, ESR, CRP), prolonged PR-interval (1st degree AV block) |
| The easier way to remember Jones Criteria for ARF: J-O-N-E-S | joints, carditis (o looks like heart), nodules, erythema marginatum, sydenham's chorea |
| The role of GAS infxn is supported by the following observations: | ARF outbreaks follow epidemics of strep throat/scarlet fever (both GAS); Tx of strep throat dec incidence of ARF; antimicrobial prophylaxis prevents recurrence in known ARF pts; most pts have elevated antistrep Abs (ASO, hyaluronidase, streptokinase) |
| How does GAS cause ARF? | infxn damages immune response by host; involves microbial antigens cross-reacting w/target organs (molecular mimicry); M-protein is good for detecting Ab production against cardiac myosin/sarcolemmal membrane and acute rheumatic heart disease |
| ARF relationship w/clinical and lab criteria | latent period of 18days; 25% have pos throat culture; rapid GAS antigen test is specific but not sensitive; only a rising/peaking titer distinguishes infxn from carrier state; 1/3 of pts don't recall prior illness |
| Specific antibodies to confirm ARF | ASO (80% of pts); anti-DNAse B; anti-streptokinase, antihyaluronidase, anti-DNAse; normal range depends on pts age, geographical location, epidemiological state, time of year; If >2 Abs are present the likelihood of disease inc |
| ARF clinical findings | Arthritis (most common; migratory/asymmetric; responds to ASA/NSAIDs); erythema marginatum (flat enlarging macule rings); Subcutaneous nodules (usu over boney prominences in kids); Sydenhams' Chorea (face, arm movements; girls); Carditis (young pts) |
| ARF Carditis suspected by: | pericarditis, cardiomegally, CHF - R or L; mitral/aortic regurgitation murmurs (mitral stenosis, cor pulmonale); Carey-Coombs Murmur |
| Carey-Coombs Mumur | dt mitral valve disease |
| Austin-flint murmur | when aortic valve has murmur too |
| ARF Carditis Specific Abnormalities | EKG has elevated P or T wave; Increased quality of heart sounds; Sinus tachycardia; Arrhythmia or ectopic beats; 1st degree AV block dt prolonged PR interval |
| Rheumatic heart disease | pay attention to mitral valve and L atrium; complication of atrial fibrillation is thrombus formation and emboli; mitral regurgitation |
| Myocardial aschoff body | elongated irregular multinucleated cells surrounded by palisading cells dt chronic inflammation; no microbe present; Pathognomonic for ARF |
| Differential for ARF | RA, osteomyelitis (fever/bone/joint pain); endocarditis, chronic meningococcemia dt sydenham's chorea; SLE; Lyme disease (erythema chronica migrans); sicke cell anemia |
| Complications of ARF | CHF in severe cases; Rheumatic heart disease; arrhythmia, pericarditis w/effusion; rheumatic pneumonitis |
| Treatment of ARF | ASA, PCN, CS; Prevention/prophylaxis of recurrent ARF - PCN, Sulfonamides/erythromycin |
| Prognosis of ARF | initial episodes (months in kids, wks in adults); 1-2% immediate mortality; Persistant RHD (poor prognosis; 30% kids die in 10yrs, 60% have abnml valves, <10% have sx heart disease) |
| Secondary prevention of RHD | continuous prophylaxis (controversial as to how long); PCN G for life; erythromycin; prophylactic antibiotics prior to invasive procedures incl dental surgery |
| RHD | results from single or repeated attacks of ARF; rigidity/deformity of valve cusps, fusion of commissures, shortend/fused chrodae dt valvular inflam; stenosis/insufficiency mostly mitral valve > aortic > tricuspid >>> pulmonary (very rare) |
| RHD details | Hx of ARF in 60%; 1st clue is murmur; echo; mitral valve; begin antigoag |
| Prophylactic antibiotics in moderate risk of significant bacteremia | dental procedures, GU procedures; lower bowel endoscopy |
| Prevention of Recurrent ARF | PCN (parenteral or oral); Sulfonamides/Erythromycin (if PCN allergic); Ampicillin, Clindamycin, Cephalosporin, Azithromycin or Clarithromycin |